Leipzig's Bayesian network matched tumor board decisions 95.1% of the time, and an audit of its own tables explains why.
A model trained on pretreatment scans can flag lung toxicity risk before immunotherapy starts, holding an AUC of about 0.83…
A Nature Medicine study spanning six countries found AI models beat standard biomarkers at forecasting immunotherapy response in advanced lung…
COMPASS, a pan-cancer foundation model, outperforms 22 methods across 16 clinical cohorts by analyzing tumor transcriptomes through immune concepts.